Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Current Assets
Cash and cash equivalents	$ 3,675	$ 4,491
Vendor advances, net	625	845
Prepaid expenses and other current assets	143	51
Total Current Assets	4,443	5,387
Deferred offering costs	1,279	1,091
Intangible assets, net	22	62
Total Other Assets	1,301	1,153
TOTAL ASSETS	5,744	6,540
Current Liabilities
Accounts payable and accrued expenses	431	199
Total Current Liabilities	431	199
Commitments and contingencies
Shareholders’ Equity
Preferred stock, par value $0.001, 20,000,000 shares authorized; no shares issued and outstanding, respectively;
Common stock, par value $0.001, 100,000,000 shares authorized; 21,411,198 and 20,821,353 shares issued and outstanding, respectively;	21	21
Additional paid-in capital	21,208	20,582
Accumulated deficit	(15,916)	(14,262)
Total Shareholders’ Equity	5,313	6,341
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 5,744	$ 6,540